Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-NF-kB p65 Antibody (2K488) (Synonyms: v-rel avian reticuloendotheliosis viral oncogene homolog A, p65, NF...)

Catalog No. TMAH-01037 Copy Product Info
🥰Excellent
Anti-NF-kB p65 Antibody (2K488) is an antibody targeting NF-kB p65. Anti-NF-kB p65 Antibody (2K488) can be used in ELISA,FCM,IF,WB.

Anti-NF-kB p65 Antibody (2K488)

Copy Product Info
🥰Excellent
Catalog No. TMAH-01037
Synonyms v-rel avian reticuloendotheliosis viral oncogene homolog A, p65, NFKB3

Anti-NF-kB p65 Antibody (2K488) is an antibody targeting NF-kB p65. Anti-NF-kB p65 Antibody (2K488) can be used in ELISA,FCM,IF,WB.

Anti-NF-kB p65 Antibody
(2K488)
Pack SizePriceUSA StockGlobal StockQuantity
50 μL$2097-10 days7-10 days
100 μL$3477-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-NF-kB p65 Antibody (2K488) is an antibody targeting NF-kB p65. Anti-NF-kB p65 Antibody (2K488) can be used in ELISA,FCM,IF,WB.
Synonymsv-rel avian reticuloendotheliosis viral oncogene homolog A, p65, NFKB3
Ig Type
Rabbit IgG
Clone
2K488
Reactivity
Human
Verified Activity
1. Western Blot
-Positive WB detected in: Hela whole cell lysate, THP-1 whole cell lysate, MCF7 whole cell lysate, A549 whole cell lysate
-All lanes: NF-kB p65 antibody at 1:500
-Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution
-Predicted band size: 70 kDa
-Observed band size: 70 kDa
2. Immunofluorescence staining of PC-3 with TMAH-01037 at 1:15, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 496-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
3. Overlay Peak curve showing Hela cells stained with TMAH-01037 (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% TritonX-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1µg/1*10^6 cells) for 45min at 4°C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG(H+L) at 1:200 dilution for 35min at 4°C.Control antibody (green line) was rabbit IgG (1µg/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.
Application
Recommended Dose
WB:1:500-1:2000; IF:1:50-1:200; FCM:1:50-1:200.
Antibody Type
Monoclonal
Subcellular LocalizationNucleus. Cytoplasm.
ConstructionRecombinant Antibody
PurificationAffinity-chromatography
AppearanceLiquid
FormulationPhosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Research BackgroundNF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric RELA-NFKB1 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. The NF-kappa-B heterodimeric RELA-NFKB1 and RELA-REL complexes, for instance, function as transcriptional activators. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The inhibitory effect of I-kappa-B on NF-kappa-B through retention in the cytoplasm is exerted primarily through the interaction with RELA. RELA shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Beside its activity as a direct transcriptional activator, it is also able to modulate promoters accessibility to transcription factors and thereby indirectly regulate gene expression. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1. Essential for cytokine gene expression in T-cells. The NF-kappa-B homodimeric RELA-RELA complex appears to be involved in invasin-mediated activation of IL-8 expression. Key transcription factor regulating the IFN response during SARS-CoV-2 infection.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
A synthetic peptide: Human RELA
Antigen Species
Human
Gene Name
RELA
Gene ID
Uniprot ID
Biology Area
Epigenetics and Nuclear Signaling, Neuroscience, Cancer, Cardiovascular, Cell biology, Metabolism, Microbiology, Signal transduction
Chemical Properties
Stability & Storage
Stability & StorageStore at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Anti-NF-kB p65 Antibody (2K488) | purchase Anti-NF-kB p65 Antibody (2K488) | Anti-NF-kB p65 Antibody (2K488) cost | order Anti-NF-kB p65 Antibody (2K488)